KER-065 is a modified Activin RII ligand trap that binds GDF8 and Activin A [5], which can be used as a standalone therapy or in combination with glucagon-like peptide-1 (GLP-1) receptor agonists
Moreover, it turned out that the sequence for human GIP differed from porcine GIP.' Without the right sequence scientists struggled to synthesise GIP in the laboratory
Schmidt discovered animal and cell research demonstrating that GLP-1s, the class of medicines that includes Ozempic and Wegovy, could treat concussions
healthcare supply chain
Lancet Diabetes Endocrinol 2(10):801809 Li K, Zou J, Ye Z, Di J, Han X, Zhang H et al (2016) Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials